eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple myeloma |
| Comorbidity | C0376358|prostate cancer |
| Sentences | 3 |
| PubMedID- 19767707 | Bisphosphonates inhibit bone resorption and are used to treat a range of pathologies, including paget disease, osteoporosis, multiple myeloma and metastases associated with breast or prostate cancer. |
| PubMedID- 25737876 | Bisphosphonates are group of drugs that inhibit bone resorption and are used to treat a range of pathologies including paget's disease, osteoporosis, multiple myeloma and metastasis associated with breast or prostate cancer. |
| PubMedID- 22409262 | Patients/methods: subjects receiving either first-line or second-line chemotherapy for advanced or metastatic lung, breast, gastrointestinal, bladder, ovarian or prostate cancers, cancer of unknown origin, myeloma or selected lymphomas were randomized to 5 mg, 10 mg or 20 mg once daily of apixaban or placebo in a double-blind manner for 12 weeks. |
Page: 1